Tourniquet
Media & Internet · 1-10 Employees
View Company Info for Free
Overview
Website
tourniquet-ojs-uh.tdl.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
About Tourniquet
Tourniquet Org Chart
Editor In Chief
Health Equity Chair Web Designer
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tourniquet your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Tourniquet
Check if Tourniquet has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Tourniquet launches new products
Earning: See what the market has to say on Tourniquet recently announced quarterly report
Funding: Get notified immidiatlly once Tourniquet has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Tourniquet, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Tourniquet is spiking on competitors!
Click to see if Tourniquet had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Top Media & Internet Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tourniquet
Tourniquet is an online, open-access medical journal established in 2022 by Sarah Snyder and medical students at the University of Houston. The journal features work from Texas residents, including medical students, healthcare professionals, and physicians, all of whom contribute through a blind review process managed by a volunteer editorial board... Read More
